title: The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis.
abstract: The 2013 Aspirin Foundation Conference covered a range of topics from clinical and medical history, epidemiology, health economics, and the current uses of aspirin in general practice and in the treatment and prevention of cancer. The use of aspirin as primary prevention in people at risk of atherosclerotic events is now well known, but its use as a preventative agent in some cancer types is still under discussion, and data on colorectal and lung cancer were presented at this meeting. The potential use of aspirin in preventing vascular disease in HIV patients was also discussed. The cost effectiveness of aspirin as a primary prevention strategy was discussed for the first time in this series of meetings.
authors.affiliation: The Croft, Pinwherry, Girvan, Ayrshire, Scotland KA26 0RU, UK.
authors.forename: Tom
authors.initials: T
authors.lastname: Smith
authors.affiliation: Cardiff University, Park Pl, Cardiff CF10 3AT, Wales, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Elwood
authors.affiliation: Wellcome Institute for the History of Medicine, Oxford University, Oxford, UK.
authors.forename: Conrad
authors.initials: C
authors.lastname: Keating
authors.affiliation: Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Rothwell
authors.affiliation: Global Medical Affairs Physician, Bayer Pharma AG 51368, Leverkusen, Germany.
authors.forename: Elmar
authors.initials: E
authors.lastname: Detering
authors.affiliation: Cardiff University and the University Hospital of Wales, Cardiff CF 14 4XW, Wales, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Freedman
authors.affiliation: MRC Clinical Trials Unit, Aviation House, 125 Kingsway, London WC2B 6NH, UK and Brighton and Sussex University Hospitals Trust, Brighton, UK.
authors.forename: Ruth
authors.initials: R
authors.lastname: Langley
authors.affiliation: University of Nottingham, University Park, Nottingham NG7 2RD, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Logan
authors.affiliation: Swansea Centre for Health Economics, Swansea University, Singleton Park, Swansea SA2 8PP, Wales, UK.
authors.forename: Ceri
authors.initials: C
authors.lastname: Phillips
authors.affiliation: Galliera Hospital, Mura delle Cappuccine 14, 16128 Genova, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: DeCensi
keywords: aspirin prophylaxis; cancer; cost-effectiveness; history; treatment; vascular disease